However, the acquisition of resistance to EGFR TKIs is almost inevitable, underscoring the importance of identifying bypass signaling pathways allowing some tumor cells to survive the initial exposure to TKIs and become metastatic (Chang et al., 2016). This evidence concerns the gene EGFR and neoplasm.